Search Legislation

Commission Decision of 17 April 2008 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2008 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2008) 1403) (Only the Danish, Dutch, English, Estonian, French, German, Italian, Slovenian and Spanish texts are authentic) (Text with EEA relevance) (2008/409/EC)

 Help about what version

What Version

Close

This is a legislation item that originated from the EU

After exit day there will be three versions of this legislation to consult for different purposes. The legislation.gov.uk version is the version that applies in the UK. The EU Version currently on EUR-lex is the version that currently applies in the EU i.e you may need this if you operate a business in the EU.

The web archive version is the official version of this legislation item as it stood on exit day before being published to legislation.gov.uk and any subsequent UK changes and effects applied. The web archive also captured associated case law and other language formats from EUR-Lex.

Status:

This is the original version (as it was originally adopted).

  1. Introductory Text

  2. Article 1.(1.) The quantity of controlled substances of Group I (chlorofluorocarbons...

  3. Article 2.The chlorofluorocarbon metered-dose inhalers listed in Annex I shall not...

  4. Article 3.During the period 1 January to 31 December 2008 the...

  5. Article 4.This Decision shall apply from 1 January 2008 and shall...

  6. Article 5.This Decision is addressed to the following undertakings: Acros Organics...

  7. Signature

    1. ANNEX I

      1. Pursuant to paragraph 3 of Decision XII/2 of the Twelfth...

    2. ANNEX II

      ESSENTIAL MEDICAL USES

      1. Quota of controlled substances of Group I that may be...

      2. Boehringer Ingelheim GmbH (DE) Chiesi Farmaceutici SpA (IT) Laboratorio Aldo...

    3. ANNEX III

      ESSENTIAL LABORATORY USES

      1. Quota of controlled substances of Groups I and II that...

      2. Bie & Berntsen (DK) Carlo Erba Reactifs-SDS (FR) CNRS —...

    4. ANNEX IV

      ESSENTIAL LABORATORY USES

      1. Quota of controlled substances of Group III that may be...

      2. Airbus France (FR) Eras Labo (FR) Ineos Fluor (UK) Ministry...

    5. ANNEX V

      ESSENTIAL LABORATORY USES

      1. Quota of controlled substances of Group IV that may be...

      2. Acros Organics (BE) Bie & Berntsen (DK) Carlo Erba Reactifs-SDS...

    6. ANNEX VI

      ESSENTIAL LABORATORY USES

      1. Quota of controlled substances of Group V that may be...

      2. Acros Organics (BE) Bie & Berntsen (DK) Merck KgaA (DE)...

    7. ANNEX VII

      LABORATORY AND ANALYTICAL CRITICAL USES

      1. Quota of controlled substances of Group VI that may be...

      2. Mebrom NV (BE) Sigma Aldrich Logistik (DE)

    8. ANNEX VIII

      ESSENTIAL LABORATORY USES

      1. Quota of controlled substances of Group VII that may be...

      2. Ineos Fluor (UK)

    9. ANNEX IX

      ESSENTIAL LABORATORY USES

      1. Quota of controlled substances of Group IX that may be...

      2. Ineos Fluor (UK) Sigma Aldrich Company (UK) Sigma Aldrich Logistik...

    10. ANNEX X

      1. This Annex is not published because it contains confidential commercial...

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources